An International, Observational Study to Evaluate the Impact of Educational Material on the Compliance and Persistence Rates to Adjuvant Aromatase Inhibitor (AI) Medication for Postmenopausal Woman
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 28 Jan 2016
At a glance
- Drugs Anastrozole (Primary) ; Letrozole
- Indications Early breast cancer
- Focus Therapeutic Use
- Acronyms CARIATIDE
- Sponsors AstraZeneca
- 12 Oct 2010 One-year results presented at the 35th Congress of the European Society for Medical Oncology
- 24 Mar 2010 Patient number changed to 2758 from 4000 as per abstract present at 7th European Breast Cancer Conference.
- 24 Mar 2010 Trial design and baseline data presented in an abstract at the 7th European Breast Cancer Conference.